Identification of a shared persistence program in triple-negative breast cancer across treatments and patients
Léa Baudre, Grégoire Jouault, Pacôme Prompsy, Mélissa Saichi, Sarah Gastineau, Christophe Huret, Laura Sourd, Ahmed Dahmani, Élodie Montaudon, Florent Dingli, Damarys Loew, Elisabetta Marangoni, Justine Marsolier, Céline Vallot
The paper identifies a shared persistence program in triple-negative breast cancer across treatments and patients, revealing key drivers and mechanisms of drug resistance.
bioRxiv · Mar 17, 2025 · PreprintCancer Biology